RYO KURASHINA, KIYOHIRO ANDO, MASAHARU INOUE, KEITA IZUMI, RIKO MARUYAMA, KOUKI MITANI, HISANORI TAKENOBU, MASAYUKI HARUTA, TOSHIHIKO IIZUKA, TAKEHIKO KAMIJO, et al. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Research. 2022. 42. 2. 1131-1136
Toshihiko Iizuka, Hiroko Nagano, Kimie Nomura, Miyako Hiramatsu, Noriko Motoi, Mingyon Mun, Yuichi Ishikawa. The combined use of long non-coding RNA HOTAIR and polycomb group protein EZH2 as a prognostic marker of lung adenocarcinoma. Cancer Treatment and Research Communications. 2022. 31. 100541-100541
Kumiko Umemoto, Yasushi Kojima, Naoyoshi Nagata, Chizu Yokoi, Toshiyuki Sakurai, Masao Kobayakawa, Toshihiko Iizuka, Toru Igari, Mikio Yanase, Junichi Akiyama. Cytomegalovirus esophagitis developing during chemoradiotherapy for esophageal cancer: two case reports. Journal of Medical Case Reports. 2016. 10. 1
Harumi Nakamura, Koji Tsuta, Hitoshi Tsuda, Yuki Katsuya, Go Naka, Toshihiko Iizuka, Toru Igari. NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: A case report and a literature review. Pathology - Research and Practice. 2015. 211. 1. 92-98
Toshihiko Iizuka, Motoji Sawabe, Kaiyo Takubo, Miao Liu, Yukio Homma, Motofumi Suzuki, Tomio Arai. hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer. SpringerPlus. 2013. 2. 1